Cargando…
Independent Drug Action in Combination Therapy: Implications for Precision Oncology
Combination therapies are superior to monotherapy for many cancers. This advantage was historically ascribed to the ability of combinations to address tumor heterogeneity, but synergistic interaction is now a common explanation as well as a design criterion for new combinations. We review evidence t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for Cancer Research
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904281/ https://www.ncbi.nlm.nih.gov/pubmed/34983746 http://dx.doi.org/10.1158/2159-8290.CD-21-0212 |